Title |
Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection / Özge Osmanoglu, Shishir K. Gupta, Anna Almasi, Seray Yagci, Mugdha Srivastava, Gabriel H. M. Araujo, Zoltan Nagy, Johannes Balkenhol, Thomas Dandekar |
|---|---|
Involved |
Özge Osmanoglu (Verfasser)
Shishir K. Gupta (Verfasser) Anna Almasi (Verfasser) Seray Yagci (Verfasser)
Mugdha Srivastava (Verfasser)
Gabriel H. M. Araujo (Verfasser) Zoltan Nagy (Verfasser) Johannes Balkenhol (Verfasser) Thomas Dandekar (Verfasser) |
Published |
Würzburg: Universität Würzburg |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
signaling network
controllability platelet SARS-CoV-2
fostamatinib
drug repurposing COVID-19 |
DDC notation |
|
Persistent identifier |
urn:nbn:de:bvb:20-opus-354158 (URN) |
Further information |
In: Frontiers in Immunology (2023) 14:1285345. https://doi.org/10.3389/fimmu.2023.1285345 |
Record ID |
1331472067 |
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: